Fibrocell Science, Inc.’s LAVIV™ Recognized in the Prestigious Wall Street Journal Technology Innovation Awards

Discover LAVIV! LAVIV (azficel T) is the first and only personalized cell therapy approved by the FDA for aesthetic use. It is indicated for the improvement of the appearance of smile lines in adults. World renowned surgeon William K. Boss, MD is the original patent holder and founder of the procedure we now call LAVIV, which Fibrocell Science, Inc. was able to carry through FDA approval.

This revolutionary treatment utilizes the patient’s own fibroblast, the cells in the body that make collagen. Dr Boss injects a person’s own cells into the treatment area to improve the appearance of smile line wrinkles.

October 16, 2012, EXTON, PA -- Fibrocell Science, Inc. announced that LAVIV™ (azficel-T) was recognized in this year’s Wall Street Journal Technology Innovation Awards. LAVIV, the first and only personalized cell treatment approved by the FDA to improve the appearance of nasolabial folds or “smile line” wrinkles, was named a runner-up in the Medicine and Biotech category. The Awards recognize companies and products that have the potential to widely impact their industries and make a difference in people’s lives.

“We are extremely pleased that The Wall Street Journal recognized LAVIV as part of its Technology Innovation Awards,” said David Pernock, Chairman and CEO of Fibrocell Science, Inc. “This award highlights the innovative technology behind LAVIV, which isolates, purifies and multiplies a patient’s own collagen-producing fibroblast cells. We look forward to advancing our fibroblast platform with new indications for unmet medical needs beyond aesthetics.”

The Wall Street Journal received 536 applications from more than two dozen countries. A team of Journal editors and reporters reviewed the entries and forwarded 172 to an independent panel of judges from venture-capital firms, universities and companies from that pool, the judges chose a total of 37 winners and runners-up in 18 categories.

About The Wall Street Journal Technology Innovation Awards In its 12th year, The Wall Street Journal Technology Innovation Awards recognize technological advances that break with conventional processes in specific fields, offer more than marginal improvements compared to existing technology and those that will have a wide impact on the industry or field.

The complete story can be found at http://online.wsj.com/public/page/technology-innovation-awards-10162012.html

If you are interested in learning more about how LAVIV can transform your skin, Call the Cosmetic Surgery & Rejuvenation Center at 1-866-725-5954 for a complimentary consultaion. Or visit our website at www.drbossmd.com